Loral Pharma Private Limited
About Loral Pharma Private Limited
Data last updated:
Loral Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 August 1989 and has been in existence for over 37 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1989PTC052972.
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Shalaka Anand Kulkarni and Sonarikar Devyani Ajay.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at K 3/13 Vishnu Mandir Chs Ltdbangur Nagar Goregaon W, Mumbai, Maharashtra, India – 400090.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.33 Lakh, a decline of 82% compared to the previous year. For the same year it recorded a net loss of ₹34,855 (net margin -15%) and EBITDA of -₹34,855 (EBITDA margin -15%). Revenue has declined at a compounded annual rate (CAGR) of 765% over three years and 11% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressK 3/13 Vishnu Mandir Chs Ltdbangur Nagar Goregaon W, Mumbai, Maharashtra, India – 400090
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Loral Pharma Private Limited FY 2025 filings available
Loral Pharma Private Limited reported revenue of ₹2.33 Lakh (down 82% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Loral Pharma Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 11% over five years, including a 82% fall in the latest year. EBITDA fell 103% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Loral Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹34,855 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹34,855 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Loral Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -15% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -15% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Loral Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Loral Pharma Private Limited
Loral Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Swami Dharmanand Food Evam Herbal Private Limited | ₹2.35 Lakh (FY 2025) | •••• | •••• | 26.0% | •••• | Haridwar, Uttarakhand, India |
| Skin India Formulations Private Limited | ₹2.34 Lakh (FY 2024) | •••• | •••• | -73.0% | •••• | Lucknow, Uttar Pradesh, India |
| Medicinea Healthcare Private Limited | ₹2.34 Lakh (FY 2025) | •••• | •••• | -42.0% | •••• | New Delhi, Delhi, India |
| Vishrudh Laboratories Private Limited | ₹2.34 Lakh (FY 2024) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Bayir Chemicals Private Limited | ₹2.33 Lakh (FY 2017) | •••• | •••• | 11.0% | •••• | Bangalore, Karnataka, India |
| Loral Pharma Private Limited this company | ₹2.33 Lakh (FY 2025) | •••• | •••• | -82.0% | •••• | Mumbai, Maharashtra, India |
| Grit Healthcare Private Limited | ₹2.31 Lakh (FY 2018) | •••• | •••• | 57.0% | •••• | Bhiwani, Haryana, India |
| Virgo Formulations Private Limited | ₹2.28 Lakh (FY 2025) | •••• | •••• | 152.0% | •••• | Meerut, Uttar Pradesh, India |
| Anvit Pharma Private Limited | ₹2.28 Lakh (FY 2016) | •••• | •••• | -98.0% | •••• | Hyderabad, Telangana, India |
| Blue Biopharma Limited | ₹2.28 Lakh (FY 2022) | •••• | •••• | -18.0% | •••• | Hyderabad, Telangana, India |
| Meark Pharma Private Limited | ₹2.26 Lakh (FY 2024) | •••• | •••• | 121.0% | •••• | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Loral Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Loral Pharma Private Limited
Loral Pharma Private Limited is audited by SHETE SHETE & CO for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SHETE SHETE & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Loral Pharma Private Limited
Loral Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shalaka Anand Kulkarni | Director | 15 Jun 2024 | 2 Years 3 Months | Current |
| Sonarikar Devyani Ajay | Director | 29 Sep 2018 | 8 Years 0 Months | Current |
| Vinayak Sadashiw Mulye | Director | 25 Oct 1999 | 26 Years 11 Months | Current |
Ownership and Shareholding of Loral Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Loral Pharma Private Limited
Loral Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Loral Pharma Private Limited
Employment history and EPFO contributions of people linked to Loral Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Loral Pharma Private Limited
Loral Pharma Private Limited has 5 board changes on record since 1999: 3 appointments and 2 cessations. The latest: Shalaka Anand Kulkarni ceased to be Additional Director on 29 Sep 2024.
Credit Ratings, Litigation & Regulatory Alerts for Loral Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Loral Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Loral Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Loral Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Loral Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Loral Pharma Private Limited
Loral Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 August 1989 (37+ years old) and is registered under CIN U24239MH1989PTC052972.
Loral Pharma reported revenue of ₹2.33 Lakh for FY 2025 (down 82% YoY).
Loral Pharma has 3 current directors:
- Shalaka Anand Kulkarni - Director
- Sonarikar Devyani Ajay - Director
- Vinayak Sadashiw Mulye - Director
Loral Pharma reported a net loss of ₹34,855 (net margin -15%) and EBITDA of -₹34,855 (EBITDA margin -15%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Loral Pharma is 765% over three years and -11% over five years. In the latest year (FY 2025) revenue fell 82%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Loral Pharma is U24239MH1989PTC052972. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Loral Pharma was incorporated on 10 August 1989, making it 37+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Loral Pharma by revenue are Swami Dharmanand Food Evam Herbal Private Limited, Skin India Formulations Private Limited, Medicinea Healthcare Private Limited, Vishrudh Laboratories Private Limited, Bayir Chemicals Private Limited and 5 more, all in the Pharma industry (Formulations).
Shalaka Anand Kulkarni ceased to be Additional Director on 29 Sep 2024. Shalaka Anand Kulkarni was appointed as Director on 15 Jun 2024. Santosh Vinayak Mulye ceased to be Director on 25 Sep 2023. Loral Pharma has 5 board changes on record in total.
The registered office of Loral Pharma is at K 313 Vishnu Mandir Chs Ltdbangur Nagar Goregaon W, Mumbai, Maharashtra, India – 400090.
Loral Pharma has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh.